Results

Total Results: 600 records

Showing results for "cardiac".
Users also searched for: ekg

  1. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_addendum.pdf
    February 01, 2010 - patient data on a set of core clinical variables consisting of demographics (age, sex, and ethnicity), cardiac … The synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) study … The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study
  2. S81 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s81.pdf
    October 01, 2007 - LOS) was �4 days and there was a complication; or if LOS was �4 days and the patient was a woman with cardiac … P-222) 0.21 7 28 94 0.61 7.1 5.32 0.0000 Length of stay �4 d† 0.21 69 90 31 0.60 2.2 3.83 0.0167 CardiacCardiac dysrhythmias and lipid disor- ders—the latter being a surrogate for coronary artery dis- ease—are
  3. effectivehealthcare-admin.ahrq.gov/products/peripheral-nerve-blocks/protocol
    May 01, 2024 - hospital stays, patient anxiety and dissatisfaction, adverse endocrine and neurovascular responses, cardiac … This comparative review will synthesize evidence of PNB effects in intrathoracic surgery, including cardiac … open or minimally invasive (laparoscopic/thoracoscopic), elective, or urgent intrathoracic surgeries*: Cardiac
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
    December 01, 2010 - diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … agranulocytosis 2. seizures 3. myocarditis 4. cardiovascular and respiratory effects, (respiratory and/or cardiac
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/cad-women-treatment-future_research.pdf
    February 01, 2013 - Associate Chief Division of Cardiothoracic Surgery Emory University School of Medicine Chief of Cardiac … clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac … “heart”[MeSH Terms] OR “heart”[All Fields] OR “coronary”[All Fields]) OR cardiovas*[All fields] OR cardiac … angina’:ab OR ‘cardiovascular diseases’:ti OR ‘heart diseases’:ti OR heart:ti OR cardiovasc*:ti OR cardiac … June 5, 2012 Set # Terms #1 cardiovascular diseases OR heart diseases OR heart OR cardiovas* OR cardiac
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_executive.pdf
    July 01, 2014 - Child Harm Outcomes • Death, including suicide, all-cause mortality, and cause-specific death (e.g., cardiac … No comparative evidence on the risk of cardiac malformations in women treated for depression during … Results were similar for cardiac malformations, except that limiting our analyses to the highest quality … significantly associated with increased risk for major malformations (OR, 1.31; 95% CI, 1.04 to 1.65) and cardiac … First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/heart-failure-natriuretic-peptide_research-protocol.pdf
    December 20, 2011 - could be used for diagnosis in acute and non-acute settings, its prognostic value for HF and other cardiac … was consistent evidence that BNP and NT-proBNP were independent predictors of mortality and other cardiac … 2005 4,14 have evaluated the evidence that BNP and NT-proBNP are predictive of mortality and other cardiac … How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/phenylketonuria_executive.pdf
    February 01, 2012 - affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … measures of executive function • Prevention of neurologic impairment • Prevention of cardiac … These include studies on the cardiac effects of BH4.
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol.pdf
    July 09, 2024 - has also been given to other common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp. 2 atherosclerosis/ or cardiac output, high/ or cardiac output, low/
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/care-adults-down-syndrome-protocol-amendment.pdf
    February 05, 2025 - has also been given to other common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp. 2 atherosclerosis/ or cardiac output, high/ or cardiac output, low/
  11. effectivehealthcare-admin.ahrq.gov/products/care-adults-down-syndrome/protocol
    February 01, 2025 - has also been given to other common co-occurring conditions such as hip dysplasia, early menopause, cardiac … syndrome" or "trisomy 21").mp.             2          atherosclerosis/ or cardiac output, high/ or cardiac
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1306.pdf
    June 01, 2013 - dissuade a physician from prescribing it for prophylaxis in patients with COPD include hearing loss and cardiac … dissuade a physician from prescribing it for prophylaxis in COPD patients include hearing loss and cardiac … Some experts stated risk of hearing loss, cardiac arrhythmias, and antibiotic resistance are factors
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_appendixes.pdf
    October 06, 2006 - Vol- Death* Dr Vol- CABG* Notes Primary Studies: National Kimmel S et al.248 Society for Cardiac … Clinical Databases: National Peterson E et al.210 Society of Thoracic Surgeons National Cardiac … Pts=patients; Hosp=hospital; vol=volume; Dr=physician; RA= Risk adjusted; AE= Adverse events; CSRS=cardiac … Clinical Databases CABG: National Peterson E et al.210 Society of Thoracic Surgeons National Cardiac … ischemia ο Other (Specify _______) Components of Primary Endpoint (N= ) ο Total Mortality ο Cardiac
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb-disposition.pdf
    March 10, 2010 - Results Pg 20, line 52- Why didn’t you think it reasonable to pool cardiovascular mortality and cardiac … which included death from vascular causes such as stroke) was an inherently different endpoint than cardiac
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/patient-generated-health-data-protocol-chronic-conditions.pdf
    March 17, 2020 - obesity, diabetes prevention, hypertension, sleep apnea, coronary artery disease, heart failure, cardiac … ti OR thrombos*:ti OR calcif*:ti)) 21 Heart Failure 'heart failure'/exp OR (((heart OR cardio* OR cardiac
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/stent-clopidogrel-practice_research.pdf
    March 01, 2009 - Collection Baseline Data Baseline demographic, medical history, physical examination and initial cardiac … contemporary patients receiving percutaneous coronary intervention, the long-term risk for death and major cardiac … Acknowledgments We acknowledge the commitment of faculty and staff of the cardiac catheterization
  17. effectivehealthcare-admin.ahrq.gov/products/antipsychotics-children/research-protocol
    December 01, 2019 - ketoacidosis Neuroleptic malignant syndrome Seizures Tardive dyskinesia Cardiomyopathies Cardiac … diabetic ketoacidosis, neuroleptic malignant syndrome, seizures, tardive dyskinesia, cardiomyopathies and cardiac … 2. seizures 3. myocarditis 4. cardiovascular and respiratory effects, (respiratory and/or cardiac
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/calcineurin-inhibitor_research-protocol.pdf
    October 08, 2014 - o include GFR threshold and how measured § New onset diabetes after transplant § Major adverse cardiac … an d timing var iation s KQ3 Adverse events: • Nephrotoxicity • New onset diabetes • Major cardiac … living (related or non-related) or deceased donor renal transplant (brain dead donors, donors after cardiac … type (living donor or deceased donor; for deceased donors: expanded criteria donors, donation after cardiac
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/phenylketonuria_research-protocol.pdf
    March 29, 2011 - affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … affecting outcomes in their infants, including prevention of neurological impairment, microcephaly, and cardiac … Prevention of cardiac defects 3. Normal growth 4. … Prevention of cardiac defects 3. Normal growth 4.
  20. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
    January 01, 2024 - app-based clinical decision support for atrial fibrillation management.20,23-25 Remote monitoring of cardiac … or software) for anticoagulation monitoring Moderate CCT = controlled clinical trial; CRT-D = cardiac … resynchronization therapy defibrillator; ICD = implantable cardiac defibrillator; PM = pacemaker; PSP … 0.80) AF = atrial fibrillation; CCT = controlled clinical trial; CI = confidence interval; CRT-D = cardiac … resynchronization therapy defibrillator; HR = hazard ratio; ICD = implantable cardiac defibrillator

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: